✅공급 중단 MSD SGLT2 당뇨병치료제, 결국 허가 취소

https://www.dailypharm.com/Users/News/NewsView.html?ID=327673

✅로수젯·케이캡, 견고한 투톱체제...팍스로비드 '껑충'

https://www.dailypharm.com/Users/News/NewsView.html?ID=327699

✅급여 확대 날개 단 키트루다·듀피젠트, 약가협상 돌입

https://www.dailypharm.com/Users/News/NewsView.html?ID=327698

✅빌베이, 알라질증후군 희귀약 지정…녹십자 리브말리와 경쟁

https://www.dailypharm.com/Users/News/NewsView.html?ID=327690

✅대원제약, 차세대 P-CAB 신약 3상 승인

https://www.dailypharm.com/Users/News/NewsView.html?ID=327705